TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Capital Work in Progress History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Capital Work in Progress | ₹281 Cr | ₹688 Cr | ₹544 Cr | ₹744 Cr | ₹577 Cr |
What is the latest Capital Work in Progress ratio of TORRENT PHARMACEUTICALS ?
Year | Capital Work in Progress |
---|---|
Mar2024 | ₹281 Cr |
Mar2023 | ₹688 Cr |
Mar2022 | ₹544 Cr |
Mar2021 | ₹744 Cr |
Mar2020 | ₹577 Cr |
How is Capital Work in Progress of TORRENT PHARMACEUTICALS Trending?
Years | Capital Work in Progress | % Change | |
---|---|---|---|
Mar2024 | ₹281 Cr | -59.20 | |
Mar2023 | ₹688 Cr | 26.44 | |
Mar2022 | ₹544 Cr | -26.83 | |
Mar2021 | ₹744 Cr | 29.01 | |
Mar2020 | ₹577 Cr | - |
Compare Capital Work in Progress of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹107,590.9 Cr | 1.4% | 1.3% | 17% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,519.0 Cr | 1.6% | -2.9% | 17.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,903.0 Cr | 1.5% | 10.4% | 51.9% | Stock Analytics | |
CIPLA | ₹121,669.0 Cr | 2.3% | 1.9% | 2.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,097.0 Cr | 5.7% | 14.1% | 15.2% | Stock Analytics | |
MANKIND PHARMA | ₹97,239.7 Cr | 0.2% | -2.4% | 12.5% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | 1.4% |
1.3% |
17% |
SENSEX | 1.3% |
2.6% |
7.8% |
You may also like the below Video Courses